8-K Announcements
6Material company update
Feb 6, 2026·SEC
Material company update
Jan 30, 2026·SEC
Material company update
Dec 30, 2025·SEC
NanoVibronix, Inc.(NAOV)Earnings, Financials & Key Ratios
NAOV•NASDAQ
Price updated May 29, 2026
AboutNanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.Show more
- Revenue$3M-0.2%
- EBITDA-$23M-539.2%
- Net Income-$18M-390.8%
- EPS (Diluted)-28.93-110.7%
- Gross Margin5.99%-89.8%
- EBITDA Margin-896.55%-540.4%
- Operating Margin-896.55%-540.3%
- Net Margin-712.3%-391.8%
- ROE-106.58%+33.6%
NAOV Key Insights
NanoVibronix, Inc. (NAOV) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y sales CAGR of 32.6%
- ✓Trading at only 0.8x book value
✗Weaknesses
- ✗Profits declining 33.3% over 5 years
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Shares diluted 100.0% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when NAOV posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
NAOV Price & Volume
NanoVibronix, Inc. (NAOV) stock price & volume — 10-year historical chart
Loading chart...
NAOV Growth Metrics
NanoVibronix, Inc. (NAOV) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years33.04%
5 Years32.59%
3 Years50.29%
TTM-18.07%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-247.68%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-82.72%
Return on Capital
10 Years-169.97%
5 Years-109.86%
3 Years-119.15%
Last Year-129.42%
NAOV Peer Comparison
NanoVibronix, Inc. (NAOV) competitors in Aesthetics, dermatology, and wound care — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ARAY | 41.39M | 0.35 | -22.45 | 2.68% | -10.76% | -77.48% | 2.17 | |
 LNTH | 6.76B | 103.86 | 30.46 | 0.5% | 18.05% | 24.33% | 0.00 | |
 STIM | 85.59M | 1.23 | -2.08 | 99.17% | -24.48% | -139.83% | 3.44 | |
 NSPR | 33.29M | 0.71 | -0.93 | 28.11% | -5.43% | -116.22% | 0.04 | |
 GKOS | 7.65B | 130.68 | -39.84 | 32.33% | -34.34% | -26.46% | 0.21 | |
 XTLB | 279.46K | 2.54 | -0.26 | -227.72% | -25.53% | 0.03 | ||
 ANGO | 505.13M | 12.15 | -14.64 | -3.76% | -9.02% | -15.71% | ||
 MMSI | 4.01B | 67.22 | 31.56 | 11.66% | 9.03% | 8.95% | 0.57 |
Compare NAOV vs Peers
NanoVibronix, Inc. (NAOV) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NAOV Income Statement
NanoVibronix, Inc. (NAOV) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 239K | 318K | 530K | 623K | 1.7M | 752K | 2.28M | 2.56M | 2.55M | 2.18M |
Revenue Growth % | 4.37% | 33.05% | 66.67% | 17.55% | 172.07% | -55.63% | 203.59% | 12.05% | -0.2% | -18.07% |
Cost of Goods Sold | 88K | 158K | 249K | 409K | 925K | 585K | 746K | 1.05M | 2.4M | 2.45M |
COGS % of Revenue | 36.82% | 49.69% | 46.98% | 65.65% | 54.57% | 77.79% | 32.68% | 41.05% | 94.01% | - |
Gross Profit | 151K▲ 0% | 160K▲ 6.0% | 281K▲ 75.6% | 214K▼ 23.8% | 770K▲ 259.8% | 167K▼ 78.3% | 1.54M▲ 820.4% | 1.51M▼ 1.9% | 153K▼ 89.9% | -271K▲ 0% |
Gross Margin % | 63.18% | 50.31% | 53.02% | 34.35% | 45.43% | 22.21% | 67.32% | 58.95% | 5.99% | -12.43% |
Gross Profit Growth % | 7.09% | 5.96% | 75.63% | -23.84% | 259.81% | -78.31% | 820.36% | -1.89% | -89.85% | - |
Operating Expenses | 3.24M | 4.46M | 5.43M | 4.93M | 6.45M | 5.18M | 4.97M | 5.09M | 20.64M | 22.08M |
OpEx % of Revenue | 1356.49% | 1403.46% | 1024.91% | 791.81% | 380.71% | 688.7% | 217.83% | 198.98% | 808.54% | - |
Selling, General & Admin | 2.55M | 3.85M | 4.92M | 4.76M | 6.16M | 4.9M | 4.79M | 4.18M | 10.13M | 11.62M |
SG&A % of Revenue | 1066.53% | 1210.38% | 927.92% | 764.37% | 363.42% | 651.06% | 209.72% | 163.45% | 396.63% | - |
Research & Development | 693K | 614K | 514K | 171K | 293K | 283K | 185K | 909K | 1.76M | 1.7M |
R&D % of Revenue | 289.96% | 193.08% | 96.98% | 27.45% | 17.29% | 37.63% | 8.1% | 35.54% | 69.02% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.75M | 1000K |
Operating Income | -3.09M▲ 0% | -4.3M▼ 39.2% | -5.15M▼ 19.7% | -4.72M▲ 8.4% | -5.68M▼ 20.4% | -5.01M▲ 11.8% | -3.44M▲ 31.4% | -3.58M▼ 4.2% | -22.89M▼ 539.0% | -24.75M▲ 0% |
Operating Margin % | -1293.31% | -1353.14% | -971.89% | -757.46% | -335.28% | -666.49% | -150.5% | -140.03% | -896.55% | -1134.71% |
Operating Income Growth % | -33.46% | -39.21% | -19.71% | 8.39% | -20.43% | 11.81% | 31.44% | -4.25% | -539% | - |
EBITDA | -3.09M | -4.3M | -5.15M | -4.72M | -5.68M | -5.01M | -3.44M | -3.58M | -22.89M | -24.77M |
EBITDA Margin % | -1291.21% | -1351.26% | -971.13% | -757.14% | -335.16% | -666.36% | -150.46% | -139.99% | -896.55% | -1135.53% |
EBITDA Growth % | -33.65% | -39.24% | -19.78% | 8.35% | -20.44% | 11.79% | 31.45% | -4.25% | -539.18% | -409.48% |
D&A (Non-Cash Add-back) | 5K | 6K | 4K | 2K | 2K | 1K | 1K | 1K | 0 | -18K |
EBIT | -3.64M | -4.28M | -5.75M | -4.16M | -14.25M | -5.41M | -3.55M | -3.69M | 0 | 2.43M |
Net Interest Income | -1.29M | 22K | -62K | -147K | 0 | -347K | -246K | -104K | 0 | 63K |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31K | 0 | 0 |
Interest Expense | 1.23M | 22K | 62K | 147K | 0 | 347K | 246K | 135K | 0 | -99K |
Other Income/Expense | -1.84M | 22K | -660K | 408K | -8.57M | -401K | -246K | -104K | 4.4M | 4.95M |
Pretax Income | -4.93M▲ 0% | -4.28M▲ 13.1% | -5.81M▼ 35.7% | -4.31M▲ 25.8% | -14.25M▼ 230.5% | -5.41M▲ 62.0% | -3.68M▲ 32.0% | -3.69M▼ 0.1% | -18.49M▼ 401.7% | -19.8M▲ 0% |
Pretax Margin % | -2061.51% | -1346.23% | -1096.42% | -691.97% | -840.71% | -719.81% | -161.28% | -144.1% | -724.32% | -907.89% |
Income Tax | 38K | -127K | -17K | 15K | 32K | 35K | 29K | 19K | 307K | 259K |
Effective Tax Rate % | -0.77% | 2.97% | 0.29% | -0.35% | -0.22% | -0.65% | -0.79% | -0.52% | -1.66% | -1.31% |
Net Income | -4.96M▲ 0% | -4.15M▲ 16.3% | -5.79M▼ 39.5% | -4.33M▲ 25.3% | -14.28M▼ 230.1% | -5.45M▲ 61.9% | -3.71M▲ 31.9% | -3.71M▲ 0.2% | -18.18M▼ 390.8% | -19.51M▲ 0% |
Net Margin % | -2077.41% | -1306.29% | -1093.21% | -694.38% | -842.6% | -724.47% | -162.55% | -144.84% | -712.3% | -894.64% |
Net Income Growth % | -75.38% | 16.33% | -39.48% | 25.34% | -230.14% | 61.85% | 31.88% | 0.16% | -390.82% | -247.68% |
Net Income (Continuing) | -4.96M | -4.15M | -5.79M | -4.33M | -14.28M | -5.45M | -3.71M | -3.71M | -18.18M | -19.51M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -200.00▲ 0% | -128.80▲ 35.6% | -167.00▼ 29.7% | -84.00▲ 49.7% | -113.50▼ 35.1% | -38.40▲ 66.2% | -21.20▲ 44.8% | -13.73▲ 35.2% | -28.93▼ 110.7% | -5.93▲ 0% |
EPS Growth % | -61.68% | 35.6% | -29.66% | 49.7% | -35.12% | 66.17% | 44.79% | 35.24% | -110.71% | -82.72% |
EPS (Basic) | -200.00 | -128.80 | -167.00 | -84.00 | -113.50 | -38.40 | -21.20 | -13.73 | -28.93 | - |
Diluted Shares Outstanding | 24.82K | 32.24K | 34.7K | 51.49K | 125.81K | 141.97K | 175.01K | 269.85K | 628.53K | 3.29M |
Basic Shares Outstanding | 24.82K | 32.24K | 34.7K | 51.49K | 125.81K | 141.97K | 175.01K | 269.85K | 628.53K | 3.29M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
NAOV Balance Sheet
NanoVibronix, Inc. (NAOV) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 4.52M | 1.23M | 1.84M | 7.97M | 8.34M | 5.61M | 6.49M | 3.33M | 7.27M | 6.2M |
Cash & Short-Term Investments | 4.36M | 896K | 1.34M | 7.14M | 7.74M | 2.71M | 3.28M | 752K | 4.22M | 2.23M |
Cash Only | 4.36M | 896K | 1.34M | 7.14M | 7.74M | 2.71M | 3.28M | 752K | 4.22M | 2.23M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 35K | 144K | 130K | 93K | 200K | 109K | 425K | 268K | 391K | 1.33M |
Days Sales Outstanding | 53.45 | 165.28 | 89.53 | 54.49 | 43.07 | 52.91 | 67.95 | 38.24 | 55.9 | 87.53 |
Inventory | 76K | 144K | 121K | 145K | 175K | 2.17M | 2.73M | 2.19M | 2.34M | 2.27M |
Days Inventory Outstanding | 315.23 | 332.66 | 177.37 | 129.4 | 69.05 | 1.36K | 1.34K | 761.63 | 355.42 | 336.87 |
Other Current Assets | 5K | 0 | 0 | 391K | 64K | 0 | 0 | 98K | 319K | 362K |
Total Non-Current Assets | 349K | 354K | 198K | 259K | 280K | 270K | 187K | 298K | 33.85M | 33.67M |
Property, Plant & Equipment | 6K | 8K | 4K | 35K | 54K | 88K | 12K | 125K | 246K | 275K |
Fixed Asset Turnover | 39.83x | 39.75x | 132.50x | 17.80x | 31.39x | 8.55x | 190.25x | 20.46x | 10.38x | 8.49x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.08M | 29.08M |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.38M | 4.17M |
Long-Term Investments | 0 | 0 | 0 | 0 | 19K | 3K | 1K | 0 | 0 | 0 |
Other Non-Current Assets | 343K | 346K | 194K | 224K | 207K | 179K | 174K | 173K | 145K | 145K |
Total Assets | 4.87M▲ 0% | 1.58M▼ 67.5% | 2.04M▲ 28.9% | 8.23M▲ 304.2% | 8.62M▲ 4.8% | 5.88M▼ 31.8% | 6.67M▲ 13.5% | 3.63M▼ 45.6% | 41.12M▲ 1033.2% | 39.87M▲ 0% |
Asset Turnover | 0.05x | 0.20x | 0.26x | 0.08x | 0.20x | 0.13x | 0.34x | 0.70x | 0.06x | 0.05x |
Asset Growth % | 884.82% | -67.52% | 28.86% | 304.17% | 4.78% | -31.81% | 13.52% | -45.62% | 1033.2% | 2888.97% |
Total Current Liabilities | 797K | 640K | 409K | 2.9M | 1.9M | 2.32M | 2.45M | 2.72M | 6.66M | 6.87M |
Accounts Payable | 168K | 193K | 129K | 144K | 87K | 66K | 138K | 47K | 0 | 0 |
Days Payables Outstanding | 696.82 | 445.85 | 189.1 | 128.51 | 34.33 | 41.18 | 67.52 | 16.34 | - | 28.36 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 89K | 95K |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 21K | 46K | 15K | 175K | 175K |
Other Current Liabilities | 410K | 447K | 280K | 2.26M | 1.77M | 2.15M | 2.27M | 47K | 6.4M | 6.77M |
Current Ratio | 5.67x | 1.92x | 4.49x | 2.75x | 4.38x | 2.42x | 2.64x | 1.22x | 1.09x | 0.90x |
Quick Ratio | 5.57x | 1.69x | 4.20x | 2.70x | 4.29x | 1.48x | 1.53x | 0.42x | 0.74x | 0.57x |
Cash Conversion Cycle | -328.14 | 52.09 | 77.8 | 55.38 | 77.79 | 1.37K | 1.34K | 783.54 | - | 396.03 |
Total Non-Current Liabilities | 434K | 477K | 279K | 2.93M | 406K | 330K | 232K | 280K | 967K | 991K |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28K | 35K |
Capital Lease Obligations | 0 | 0 | 0 | 18K | 0 | 0 | 0 | 64K | 0 | 84K |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 434K | 477K | 279K | 2.72M | 406K | 223K | 217K | 216K | 939K | 956K |
Total Liabilities | 1.23M | 1.12M | 688K | 5.83M | 2.31M | 2.65M | 2.69M | 3M | 7.63M | 7.86M |
Total Debt | 0 | 0 | 0 | 31K | 49K | 81K | 5K | 116K | 117K | 130K |
Net Debt | -4.36M | -896K | -1.34M | -7.11M | -7.69M | -2.63M | -3.28M | -636K | -4.11M | -2.1M |
Debt / Equity | - | - | - | 0.01x | 0.01x | 0.03x | 0.00x | 0.19x | 0.00x | 0.00x |
Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.01x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 0.08x |
Interest Coverage | -2.95x | -194.59x | -92.73x | -28.33x | - | -15.60x | -14.42x | -27.30x | - | -24.52x |
Total Equity | 3.63M▲ 0% | 463K▼ 87.3% | 1.35M▲ 191.1% | 2.39M▲ 77.6% | 6.31M▲ 163.7% | 3.23M▼ 48.8% | 3.99M▲ 23.4% | 627K▼ 84.3% | 33.5M▲ 5242.4% | 32.02M▲ 0% |
Equity Growth % | 245.42% | -87.26% | 191.14% | 77.6% | 163.7% | -48.79% | 23.35% | -84.28% | 5242.42% | 8725.29% |
Book Value per Share | 146.41 | 14.36 | 38.85 | 46.49 | 50.18 | 22.77 | 22.79 | 2.32 | 53.29 | 9.73 |
Total Shareholders' Equity | 3.63M | 463K | 1.35M | 2.39M | 6.31M | 3.23M | 3.99M | 627K | 33.5M | 32.02M |
Common Stock | 4K | 4K | 5K | 22K | 1K | 2K | 2K | 3K | 1K | 4K |
Retained Earnings | -28.38M | -32.54M | -38.33M | -42.66M | -56.94M | -62.38M | -66.1M | -69.8M | -90.48M | -112.14M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -45K | -50K | 0 | 66K | 60K | -18K | -67K | -80K | -80K | -80K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAOV Cash Flow Statement
NanoVibronix, Inc. (NAOV) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -2.18M | -3.55M | -3.87M | -3.39M | -4.37M | -7.04M | -3.6M | -2.52M | -9.37M | -12.34M |
Operating CF Margin % | -912.97% | -1116.35% | -730.94% | -544.3% | -257.64% | -935.51% | -157.77% | -98.36% | -367.1% | - |
Operating CF Growth % | -42.34% | -62.69% | -9.13% | 12.47% | -28.78% | -61.09% | 48.8% | 30.15% | -272.5% | -1256.79% |
Net Income | -4.96M | -4.15M | -5.79M | -4.33M | -14.28M | -5.45M | -3.71M | -3.71M | -18.18M | -19.51M |
Depreciation & Amortization | 5K | 6K | 4K | 2K | 2K | 1K | 1K | 1K | 897K | 1.1M |
Stock-Based Compensation | 800K | 889K | 1.75M | 376K | 382K | 354K | 293K | 356K | 0 | 0 |
Deferred Taxes | 549K | 0 | 598K | -536K | 8.53M | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 1.2M | 1.01M | 10K | 647K | 1.5M | 363K | 137K | 101K | 7.92M | 4.07M |
Working Capital Changes | 232K | -291K | -447K | 445K | -494K | -2.31M | -322K | 731K | 0 | 1.91M |
Change in Receivables | -18K | -71K | -16K | 86K | -175K | 191K | -309K | 85K | -179K | -666K |
Change in Inventory | -9K | -68K | 23K | -26K | -30K | -2M | -557K | 541K | 249K | -247K |
Change in Payables | 86K | 25K | -64K | 15K | -59K | -21K | 54K | -91K | 1.02M | 43K |
Cash from Investing | 0 | -8K | 0 | -2K | -3K | -3K | -1K | -3K | 88K | -72K |
Capital Expenditures | 0 | -8K | 0 | -2K | -3K | -3K | -1K | -3K | -60K | -72K |
CapEx % of Revenue | - | 2.52% | - | 0.32% | 0.18% | 0.4% | 0.04% | 0.12% | 2.35% | 3.3% |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 148K | 0 |
Cash from Financing | 6.44M | 94K | 4.32M | 9.52M | 4.58M | 2.09M | 4.22M | 1K | 12.79M | 14.08M |
Debt Issued (Net) | 1.38M | 0 | 0 | 42K | 0 | 0 | 0 | 0 | 0 | 17.36M |
Equity Issued (Net) | 5.06M | 0 | 4.25M | 9.48M | 4.97M | 2.09M | 4.21M | 1K | 0 | -5.59M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5M |
Other Financing | 0 | 94K | 66K | 1K | -388K | 2K | 7K | 0 | 12.79M | 2.31M |
Net Change in Cash | 4.25M▲ 0% | -3.46M▼ 181.4% | 442K▲ 112.8% | 6.2M▲ 1301.6% | 204K▼ 96.7% | -5.02M▼ 2562.7% | 570K▲ 111.3% | -2.53M▼ 544.0% | 3.5M▲ 238.4% | 1.66M▲ 0% |
Free Cash Flow | -2.18M▲ 0% | -3.56M▼ 63.1% | -3.87M▼ 8.9% | -3.39M▲ 12.4% | -4.37M▼ 28.8% | -7.04M▼ 61.1% | -3.6M▲ 48.8% | -2.52M▲ 30.1% | -9.43M▼ 274.4% | -12.41M▲ 0% |
FCF Margin % | -912.97% | -1118.87% | -730.94% | -544.62% | -257.82% | -935.9% | -157.82% | -98.48% | -369.45% | -569.14% |
FCF Growth % | -41.6% | -63.06% | -8.88% | 12.42% | -28.79% | -61.05% | 48.81% | 30.09% | -274.43% | -277.64% |
FCF per Share | -87.91 | -110.35 | -111.66 | -65.90 | -34.73 | -49.57 | -20.59 | -9.33 | -15.01 | -3.77 |
FCF Conversion (FCF/Net Income) | 0.44x | 0.85x | 0.67x | 0.78x | 0.31x | 1.29x | 0.97x | 0.68x | 0.52x | 0.64x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAOV Key Ratios
NanoVibronix, Inc. (NAOV) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -874.89% | -202.78% | -639.87% | -231.21% | -328.06% | -114.14% | -102.78% | -160.56% | -106.58% | -52.57% |
Return on Invested Capital (ROIC) | - | - | -38632.5% | - | - | -625.46% | -393.13% | -766.48% | -116.86% | -54.37% |
Gross Margin | 63.18% | 50.31% | 53.02% | 34.35% | 45.43% | 22.21% | 67.32% | 58.95% | 5.99% | -12.43% |
Net Margin | -2077.41% | -1306.29% | -1093.21% | -694.38% | -842.6% | -724.47% | -162.55% | -144.84% | -712.3% | -894.64% |
Debt / Equity | - | - | - | 0.01x | 0.01x | 0.03x | 0.00x | 0.19x | 0.00x | 0.00x |
Interest Coverage | -2.95x | -194.59x | -92.73x | -28.33x | - | -15.60x | -14.42x | -27.30x | - | -24.52x |
FCF Conversion | 0.44x | 0.85x | 0.67x | 0.78x | 0.31x | 1.29x | 0.97x | 0.68x | 0.52x | 0.64x |
Revenue Growth | 4.37% | 33.05% | 66.67% | 17.55% | 172.07% | -55.63% | 203.59% | 12.05% | -0.2% | -18.07% |
Related:NAOV Dividend History·NAOV Revenue History·NAOV Price History·NAOV P/E History·NAOV Financial Ratios·NAOV Institutional Holders
NAOV SEC Filings & Documents
NanoVibronix, Inc. (NAOV) SEC filings — annual & quarterly reports (10-K, 10-Q)
NAOV Frequently Asked Questions
NanoVibronix, Inc. (NAOV) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
NanoVibronix, Inc. (NAOV) reported $2.2M in revenue for fiscal year 2025. This represents a 2220% increase from $0.1M in 2011.
NanoVibronix, Inc. (NAOV) saw revenue decline by 0.2% over the past year.
NanoVibronix, Inc. (NAOV) reported a net loss of $19.5M for fiscal year 2025.
Dividend & Returns
NanoVibronix, Inc. (NAOV) has a return on equity (ROE) of -106.6%. Negative ROE indicates the company is unprofitable.
NanoVibronix, Inc. (NAOV) had negative free cash flow of $12.4M in fiscal year 2025, likely due to heavy capital investments.